Healthcare -
Biotechnology - NASDAQ - US
$ 4.1375
-0.541 %
$ 86.1 M
Market Cap
-0.7
P/E
ADVM - OPERATING EXPENSES
Operating Expenses ADVM - Adverum Biotechnologies, Inc.
128 M
LAST VALUE
-8.87%
2 YEAR CAGR
11.30%
5 YEAR CAGR
43.47%
10 YEAR CAGR